Skip Navigation
Text Size
A A A
Home > ARRA Stories > Professor Grabs NIH Grant; Scientist Will Conduct Research on Tuberculosis
Professor Grabs NIH Grant; Scientist Will Conduct Research on Tuberculosis

By Gabrielle Bluestone

October 15, 2009

Photo of Cynthia Dowd in her lab

Media Credit: Michelle Rattinger, assistant photo editor.

Chemistry professor Cynthia Dowd earns a National Institutes of Health grant to pursue research on treatment for tuberculosis.

A chemistry professor has secured a grant for an estimated $720,000 from the National Institutes of Health to expand drug research on tuberculosis.

Cynthia Dowd, who has explored the development of small molecules as a treatment for tuberculosis, was awarded the grant over stiff competition - only 1 percent of applications receive funding. Dowd said the exact numbers have not yet been decided, but her grant will be "in the neighborhood of about $720,000."

The NIH received $200 million in stimulus funds to dole out to projects.

Dowd said she will put the money toward research she has already begun in the laboratory, in which she uses organic synthesis to test molecules against specific targets in the hopes of finding a treatment for tuberculosis.

"The grant funds people in my lab to do this work, as well as some equipment, and to do the synthesis and testing of the compounds," Dowd said. "They're two-year awards and mine is specifically towards drug discovery for tuberculosis, which is work that I've started already here at GW, and the grant will help me accelerate that work."

The grant is part of a stimulus fund challenge competition. More than 20,000 applications were submitted for the available $200 million, creating the 1 percent acceptance rate.

"It's more stringent a standard than has ever been applied to any competition, to the best of my knowledge. That's one of the reasons Cynthia Dowd has to be commended, that she actually got a 1-percentile score," said Anne Hirshfield, associate vice president for health research. "They expected to get a few thousand applications and got over 20,000 applications. And nobody was expecting that size of response."

Dowd said she was thrilled to receive the grant.

"I feel fantastic, obviously. It's a great opportunity for anyone to advance their work, and specifically to a young investigator like myself, it's a great chance to really get out of the gates and start running immediately," said Dowd, who is in her late 30s.

Dowd created molecules based on fosmidomycin, a compound that successfully killed the bacteria in tuberculosis this past summer, according to a University news release. She is now focusing on changing the structure of fosmidomycin to specifically combat tuberculosis.

Dowd's grant comes as one of several awarded to GW research teams. The University has received nearly $13 million in grants from the NIH and the National Science Foundation this year, and 52 proposals are still pending, Hirshfield said last week.

This article written by Gabrielle Bluestone originally appeared in the GW Hatchet with photo by Michelle Rattinger. Reposted with permission.

Related Links


Search Stories:





Project Details



Research/Disease Category

  • Antimicrobial Resistance
  • Emerging Infectious Diseases
  • HIV/AIDS
  • Infectious Diseases
  • Tuberculosis
Check this website regularly for new stories of advancement and discovery.